Lysophosphatidylcholine molecular species in low density lipoprotein of type 2 diabetes

Hormone and Metabolic Research

Volumn 31, Issue 4, 1999, Pages 283-286

  Shi, A H ^a   Yoshinari, Mototaka ^a   Wakisaka, M ^a   Iwase, M ^a   Fujishima, M ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Low Density Lipoprotein; Lysophosphatidylcholine; Type 2 DM

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; PALMITIC ACID; STEARIC ACID;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC ANGIOPATHY; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; JAPAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0032890861     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978734     Document Type: Article

References (26)

1. 1. Kume N, Cybulsky MI, Gimbrone MA Jr. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992; 90: 1138-44
2. 2. Cowan CL, Steffen RP. Lysophosphatidylcholine inhibits relaxation of rabbit abdominal aorta mediated by endothelium-derived nitric oxide and endothelium-derived hyperpolarizing factor independent of protein kinase C activation. Arterioscler Thromb Vasc Biol 1995; 15: 2290-7
3. 2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth cells. Atherosclerosis 1995; 112: 69-76
4. 4. Sakai M, Miyazaki A, Hakamata H, Sasaki T, Yui S, Yamazaki M, Shichiri M, Horiuchi S. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages. J Biol Chem 1994; 269: 31430-5
5. 5. Sakai M, Miyazaki A, Hakamata H, Sato Y, Matsumura T, Kobori S, Shichiri M, Horiuchi S. Lysophosphatidylcholine potentiates the mitogenic activity of modified LDL for human monocyte-derived macrophages. Arterioscler Thromb Vasc Biol 1996; 16: 600-5
6. +-AT-Pase activity and plasma lysophosphatidylcholine concentrations in diabetic patients. Diabetes 1994; 43: 915-9
7. 7. Bagdade JD, Subbaiah PV. Abnormal high-density lipoprotein composition in women with insulin-dependent diabetes. J Lab Clin Med 1989; 113: 235-40
8. 8. Takahara N, Kashiwagi A, Nishio Y, Harada N, Kojima H, Maegawa H, Hidaka H, Kikkawa R. Oxidized lipoproteins found in patients with NIDDM stimulate radical-induced monocyte chemoattractant protein-1 mRNA expression in cultured human endothelial cells. Diabetes 1997; 40: 662-70
9. 9. Subbaiah PV, Liu M. Disparate effects of oxidation on plasma acyltransferase activities: inhibition of cholesterol esterification but stimulation of transesterification of oxidized phospholipids. Biochim Biophys Acta 1996; 1301: 115-26
10. 10. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Structural differences in the ability of lysophospholipids to inhibit endothelium-dependent hyperpolarization by acetylcholine in rat mesenteric arteries. Biochem Biophys Res Commun 1996; 227: 479-83
11. 2+ sensitivity in a-toxin-permeabilized small mesenteric artery from the rat. Br J Pharmacol 1996; 117: 1238-44
12. 12. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem 1974; 20: 470-5
13. 13. Tamaoku K, Ueno K, Akiura K, Ohkura Y. New water-soluble hydrogen donors for the enzymatic photometric determination of hydrogen peroxide, II, N-ethyl-N-(2-hydroxy-3-sulfopropyl)-aniline derivatives. Chem Pharm Bull 1982; 30: 2492-7
14. 14. Allen JK, Hensley WJ, Nicholls AV, Whitfield JB. An enzymic and centrifugal method for estimating high-density lipoprotein cholesterol. Clin Chem 1979; 25: 325-7
15. 15. Banauch D, Brummer W, Ebeling W. Eine Glucose-Dehydrogenase für die Glucose-Bestimmung in Körperflüssigkeiten. Z Klin Chem Klin Biochem 1975; 13: 101-7
16. 16. Cole RA, Soeldner JS, Dunn PJ, Bunn HF. A rapid method for the determination of glycosylated hemoglobins using high pressure liquid chromatography. Metabolism 1978; 27: 289-301
17. 17. Havel RJ, Eder HA, Bragdon JH. The determination and chemical composition of ultra centrifugally separated lipoprotein in human serum. J Clin Invest 1955; 34: 1345-53
18. 18. Takayama M, Itoh S, Nagasaki T, Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 1977; 79: 93-8
19. 19. Wells I, Peitzmeier G, Vincent JK. Lecithin: cholesterol acyltransferase and lysolecithin in coronary atherosclerosis. Exp Mol Pathol 1986; 45: 303-10
20. 20. Murugesan G, Fox PL. Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein. J Clin Invest 1996; 97: 2736-44
21. 21. Nakano T, Raines EW, Abraham JA, Lagsbrun M, Ross R. Lysophosphatidylcholine upregulates the level of heparin-binding epidermal growth factor-like growth factor mRNA in human monocytes. Proc Natl Acad Sci USA 1994; 91: 1069-73
22. 22. Tsai EC, Hirsch IB, Brunzell JD, Chait A. Reduced plasma peroxyl radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 1994; 43: 1010-4
23. 23. Ceriello A, Giacomello R, Stel G, et al. . Hyperglycemia-induced thrombin formation in diabetes. Diabetes 1995; 44: 924-8
24. 24. Dobrian A, Simionescu M. Irreversibly glycated albumin alters the physico-chemical characteristics of low density lipoproteins of normal and diabetic subjects. Biochim Biophys Acta 1995; 1270: 26-35
25. 25. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 1993; 42: 801-13
26. 26. Urata Y, Yamamoto H, Goto S, Tsushima H, Akazawa S, Yamashita S, Nagataki S, Kondo T. Long exposure to high glucose concentration impairs the responsive expression of gamma-glutamylcysteine synthetase by interleukin-1beta and tumor necrosis factor-alpha in mouse endothelial cells. J Biol Chem 1996; 271: 15146-52